Trial Profile
Etanercept biosimilar (Etanar) compared with adalimumab and infliximab in a cohort of real-life patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2015
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Adalimumab; Infliximab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 24 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.